Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the adequacy of the availability of covid-19 booster vaccines for people who are clinically vulnerable.

The United Kingdom has sufficient supply of vaccines to meet the current advice from the Joint Committee on Vaccination and Immunisation for the 2023 spring and autumn booster campaigns. This includes agreements with Pfizer/BioNTech, Moderna, Sanofi/GSK and Novavax, which the Medicines and Healthcare products Regulatory Agency has approved for use in the UK. We remain in regular contact with the vaccine manufacturers to ensure the future supply of vaccines to the UK.